Women and children with psychotic disorders in developing countries may be vulnerable and have considerable social disadvantages. Gender disadvantage has implications for all health outcomes including mental illnesses. In the more relevant gender-related context we discuss several important issues which affect women with schizophrenia, namely stigma, caregiver burden, functional outcome, marriage, victimization and help-seeking. The fi ndings indicate that there are variations in clinical and functional outcomes and age of onset of illness between different regions. Drug side effects, such as metabolic syndrome appear to be quite common, adding to disease burden in women from developing countries. Victimization and coercion may contribute to poor quality of life and health concerns such as STIs and HIV. Stigma among women with schizophrenia appears to play a major role in help-seeking, caregiver burden and issues such as marriage and parenting. Gender-sensitive care and practices are few and not well documented. Research in the area of psychoses in children and adolescents from LAMI countries is sparse and is mainly restricted to a few clinic-based studies. More research is needed on organic and medical factors contributing to childhood psychoses, pathways to care, help-seeking, and impact of early detection and community care. Part I: Introduction When one discusses the concept of gender in the context of mental illness among women it is important to defi ne what we mean by the terms gender and sex. ‘ Sex ’ refers to the biological and physiological characteristics that defi ne men and women, while ‘ gender ’ refers to the socially constructed roles, behaviours, activities, and attributes that a given society considers appropriate for men and women. In this review on women and schizophrenia in low and middle income (LAMI) developing countries, while we have tried to focus on certain specifi c issues that are related to the female sex and schizophrenia, much of the discussion focuses on gender and how it shapes the schizophrenia experience. Gender disadvantage has implications for all health outcomes including mental illnesses. The many reports on better outcomes for schizophrenia among women sometimes fail to take into account those women who suffer gender-related disadvantage that might not contribute to symptom outcome but have an important role in functional outcome and recovery. In literature, gender disadvantage is synonymously referred to as gender discrimination, gender inequality, and gender disparities. These include poverty, limited access to resources such as nutrition, education, employment, healthcare, child gender preference, workplace harassment, migration and exposure to disasters. In this review we deliberately focus on two issues related to schizophrenia and biological sex, namely age of onset and antipsychotic-related metabolic syndrome. These two topics were chosen because of the slight variations in fi ndings between the developed and developing world related to the former and the important healthcare implications of the latter. In the more relevant gender-related context we discuss several important issues which affect women with schizophrenia, namely stigma, caregiver burden, functional outcome, marriage, victimization and help-seeking.